Skip to content
Open access · CC-BY via OpenAlex

Sex differences in pharmacological interventions and their effects on lifespan and healthspan outcomes: a systematic review

M. Knufinke, Michael R. MacArthur, Collin Y. Ewald, Sarah J. Mitchell

Frontiers in Aging · 2023 · ▲ 20 citations

Abstract

With an increasing aging population, the burden of age-related diseases magnifies. To alleviate this burden, geroprotection has been an area of intense research focus with the development of pharmacological interventions that target lifespan and/or healthspan(definition). However, there are often sex differences, with compounds mostly tested in male animals. Given the importance of considering both sexes in preclinical research, this neglects potential benefits for the female population, as interventions tested in both sexes often show clear sexual dimorphisms in their biological responses. To further understand the prevalence of sex differences in pharmacological geroprotective intervention studies, we performed a systematic review of the literature according to the PRISMA guidelines. Seventy-two studies met our inclusion criteria and were classified into one of five subclasses: FDA-repurposed drugs, novel small molecules, probiotics, traditional Chinese medicine, and antioxidants, vitamins, or other dietary supplements. Interventions were analyzed for their effects on median and maximal lifespan and healthspan markers, including frailty, muscle function and coordination, cognitive function and learning, metabolism, and cancer. With our systematic review, we found that twenty-two out of sixty-four compounds tested were able to prolong both lifespan and healthspan measures. Focusing on the use of female and male mice, and on comparing their outcomes, we found that 40% of studies only used male mice or did not clarify the sex. Notably, of the 36% of pharmacologic interventions that did use both male and female mice, 73% of these studies showed sex-specific outcomes on healthspan and/or lifespan. These data highlight the importance of studying both sexes in the search for geroprotectors, as the biology of aging is not the same in male and female mice. Systematic Review Registration: [website], identifier [registration number].

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3389/fragi.2023.1172789
Canonical
link ↗
Fetched
2026-06-14 MST

Cite this

APA
Knufinke, M., MacArthur, M.R., Ewald, C.Y., &amp; Mitchell, S.J. (2023). Sex differences in pharmacological interventions and their effects on lifespan and healthspan outcomes: a systematic review. <em>Frontiers in Aging</em>. https://doi.org/10.3389/fragi.2023.1172789
Vancouver
Knufinke M, MacArthur MR, Ewald CY, Mitchell SJ. Sex differences in pharmacological interventions and their effects on lifespan and healthspan outcomes: a systematic review. Frontiers in Aging. 2023. doi:10.3389/fragi.2023.1172789.
BibTeX
@article{m2023Sexdif, title = {Sex differences in pharmacological interventions and their effects on lifespan and healthspan outcomes: a systematic review}, author = {M. Knufinke and Michael R. MacArthur and Collin Y. Ewald and Sarah J. Mitchell}, journal = {Frontiers in Aging}, year = {2023}, doi = {10.3389/fragi.2023.1172789}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings